Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial.
de Groot PF, Nikolic T, Imangaliyev S, Bekkering S, Duinkerken G, Keij FM, Herrema H, Winkelmeijer M, Kroon J, Levin E, Hutten B, Kemper EM, Simsek S, Levels JHM, van Hoorn FA, Bindraban R, Berkvens A, Dallinga-Thie GM, Davids M, Holleman F, Hoekstra JBL, Stroes ESG, Netea M, van Raalte DH, Roep BO, Nieuwdorp M.
de Groot PF, et al. Among authors: davids m.
Diabetologia. 2020 Mar;63(3):597-610. doi: 10.1007/s00125-019-05073-8. Epub 2020 Jan 8.
Diabetologia. 2020.
PMID: 31915895
Clinical Trial.